Biopharmaceutical firm Protemix has gone into liquidation owing $2.15 million to creditors after burning through $61 million of shareholder funds.The liquidation is a sad end to what had been a highly promising venture set up by Professor Garth Cooper and
Duncan Bridgeman Mon, 19 Jul 2010
Biopharmaceutical firm Protemix has gone into liquidation owing $2.15 million to creditors after burning through $61 million of shareholder funds.
The liquidation is a sad end to what had been a highly promising venture set up by Professor Garth Cooper and John Baker 15 years ago.
Protemix had
Want to read more? It's easy.
Choose your best value subscription option
Student
Exclusive offer for uni students studying at a New Zealand university (valued at $499).
